BR1100311A - Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica - Google Patents

Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Info

Publication number
BR1100311A
BR1100311A BR1100311-1A BR1100311A BR1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A BR 1100311 A BR1100311 A BR 1100311A
Authority
BR
Brazil
Prior art keywords
pct
antimitotic
alkaloids
medication
binary
Prior art date
Application number
BR1100311-1A
Other languages
English (en)
Inventor
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Original Assignee
Jean-Claude Jacquesy
Jacques Fahy
Christian Berrier
Dennis Bigg
Marie Paule Jouannetaud
Fabien Zunino
Anna Kruczynski
Robert Kiss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100311(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jean-Claude Jacquesy, Jacques Fahy, Christian Berrier, Dennis Bigg, Marie Paule Jouannetaud, Fabien Zunino, Anna Kruczynski, Robert Kiss filed Critical Jean-Claude Jacquesy
Publication of BR1100311A publication Critical patent/BR1100311A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR1100311-1A 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica BR1100311A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308948A FR2707988B1 (fr) 1993-07-21 1993-07-21 Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Publications (1)

Publication Number Publication Date
BR1100311A true BR1100311A (pt) 1999-08-31

Family

ID=9449457

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100311-1A BR1100311A (pt) 1993-07-21 1997-04-22 Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica

Country Status (15)

Country Link
US (1) US5620985A (pt)
EP (1) EP0710240B1 (pt)
JP (1) JP3606872B2 (pt)
AT (1) ATE146477T1 (pt)
AU (1) AU693460B2 (pt)
BR (1) BR1100311A (pt)
CA (1) CA2167694C (pt)
DE (2) DE122010000012I1 (pt)
DK (1) DK0710240T3 (pt)
ES (1) ES2097659T3 (pt)
FR (2) FR2707988B1 (pt)
GR (1) GR3022659T3 (pt)
LU (1) LU91660I2 (pt)
NZ (2) NZ269172A (pt)
WO (1) WO1995003312A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737208A1 (fr) * 1995-07-28 1997-01-31 Pf Medicament Nouvelles fluorovindolines, precurseurs d'analogues de la vinblastine et de la vinorelbine,leurs procedes de preparation et leur utilisation comme medicament
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
FR2783522A1 (fr) * 1998-09-21 2000-03-24 Pf Medicament Composes derives d'alcaloides de vinca, leur preparation et leur application en therapeutique
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1689395B1 (en) 2003-12-04 2016-02-17 Albany Molecular Research, Inc. Vinca derivatives
US7235564B2 (en) 2003-12-04 2007-06-26 Amr Technology, Inc. Vinorelbine derivatives
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
EP1732947B1 (en) * 2004-03-05 2011-04-27 Vegenics Pty Ltd Growth factor binding constructs materials and methods
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
EP1989212B1 (en) * 2006-02-17 2013-06-19 Cascade Prodrug Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (zh) * 2006-07-17 2008-01-23 上海恒瑞医药有限公司 长春碱类化合物、其制备方法及其在医药上的用途
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
CN101235046B (zh) * 2007-01-29 2010-09-08 中国科学院上海药物研究所 长春碱衍生物、其制备方法和用途、以及包含该衍生物的药物组合物
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
EP1997534A1 (en) * 2007-05-31 2008-12-03 Pierre Fabre Medicament Cancer treatment combination therapy comprising vinflunine and trastuzumab
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
ES2575160T3 (es) 2010-03-15 2016-06-24 The Board Of Trustees Of The University Of Illinois Inhibidores de las interacciones que unen la subunidad alfa de la beta integrina-proteína G
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
WO2012087943A2 (en) 2010-12-20 2012-06-28 The Regents Of The University Of Michigan Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
CN103788117A (zh) * 2012-10-30 2014-05-14 何小解 一种脱水长春碱、长春瑞滨及长春氟宁连续化合成工艺
HU230462B1 (hu) 2013-05-30 2016-07-28 Richter Gedeon Nyrt. Új bisz-indol alkaloidok mint rákellenes gyógyszerek
AU2015205995A1 (en) 2014-01-15 2016-07-28 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
EP3250611B1 (en) 2015-01-26 2021-04-21 The University of Chicago Car t-cells recognizing cancer-specific il 13r-alpha2
JP7264592B2 (ja) 2015-01-26 2023-04-25 ザ ユニバーシティー オブ シカゴ ＩＬ１３Ｒα２結合剤及び癌治療におけるその使用
CA3014473A1 (en) * 2016-03-09 2017-09-14 Synbias Pharma Ag Vinorelbine monotartrate and its pharmaceutical use
EP3481422A1 (en) 2016-07-06 2019-05-15 Pierre Fabre Medicament Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
JP2020530003A (ja) 2017-08-07 2020-10-15 アムジェン インコーポレイテッド 抗ｐｄ−ｌ１抗体及び腫瘍溶解性ウイルスでの、肝転移を伴う三種陰性乳がん又は結腸直腸がんの処置
BR112021018608A2 (pt) 2019-03-20 2021-11-23 Univ California Anticorpos para claudina-6 e conjugados de fármaco
CA3134056A1 (en) 2019-03-20 2020-09-24 The Regents Of The University Of California Claudin-6 bispecific antibodies
AU2020266083A1 (en) 2019-04-30 2021-09-23 Instituto de Medicina Molecular João Lobo Antunes Rank pathway inhibitors in combination with CDK inhibitors
CA3140904A1 (en) 2019-06-24 2020-12-30 Amgen Inc. Inhibition of sirp-gamma for cancer treatment
FR3140369A1 (fr) 2022-10-04 2024-04-05 Universite De Poitiers Procédé de fluoration et/ou cyclisation d’un alcène ou alcyne aminé en flux continu et installation pour la mise en œuvre du procédé

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296418B1 (pt) * 1974-12-30 1978-07-21 Anvar
US4110330A (en) * 1977-05-27 1978-08-29 Eli Lilly And Company 5'-Acetonylvincristine and related compounds
US4203898A (en) * 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) * 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4320058A (en) * 1980-12-29 1982-03-16 Eli Lilly And Company 20'-Hydroxyvinblastine and related compounds
HU193772B (en) * 1985-06-12 1987-11-30 Richter Gedeon Vegyeszet Process for producing new nitro-bis-indole derivatives

Also Published As

Publication number Publication date
LU91660I2 (fr) 2010-05-10
FR10C0012I1 (pt) 2010-04-16
CA2167694C (fr) 2007-03-06
EP0710240A1 (fr) 1996-05-08
NZ328612A (en) 2000-05-26
FR2707988A1 (fr) 1995-01-27
ATE146477T1 (de) 1997-01-15
US5620985A (en) 1997-04-15
JP3606872B2 (ja) 2005-01-05
CA2167694A1 (fr) 1995-02-02
DE69401216D1 (de) 1997-01-30
AU7266694A (en) 1995-02-20
EP0710240B1 (fr) 1996-12-18
ES2097659T3 (es) 1997-04-01
NZ269172A (en) 1997-10-24
DE122010000012I1 (de) 2010-07-08
FR2707988B1 (fr) 1995-10-13
GR3022659T3 (en) 1997-05-31
DK0710240T3 (da) 1997-06-02
WO1995003312A1 (fr) 1995-02-02
AU693460B2 (en) 1998-07-02
FR10C0012I2 (pt) 2011-04-01
JPH09500634A (ja) 1997-01-21
DE69401216T2 (de) 1997-07-03

Similar Documents

Publication Publication Date Title
BR1100311A (pt) Compostos derivados antimitóticos dos alcalóides binários do catharanthus roseus: seu processo de preparação, medicamento e composição farmacêutica
ATE201019T1 (de) 9-deoxotaxan verbindungen
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
NO180583C (no) Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
RU94036004A (ru) Промежуточные соединения для получения ароматических аминоспиртовых производных
TR200001344T2 (tr) Sikline bağlı kinazların aminotiyazol önleyicileri.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
ATE304543T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
NO972128L (no) 2,2-dikloralkankarboksylsyrer, fremgangsmåte for fremstilling av disse, legemiddel inneholdende disse og anvendelse derav for behandling av insulinresistens
RU94036761A (ru) Производные галантамина и фармацевтическая композиция
ATE170530T1 (de) Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten
BR9807944A (pt) Derivados antimitóticos dos alcalóides da vinca, compostos, processo para preparar os compostos, processo para preparar a 4'-desóki-20', 20'-difluorovinblastina, processo para preparar a 20', 20'-diflúoro-3', 4'-diidrovinorrelbina ou vinflunina, produtos medicinais, e, composição farmacêutica
PL306402A1 (en) Thiazole derivatives, method of obtaining them and pharmaceutical preparations containing such derivatives
DK0728138T3 (da) Anthracyclinderivater
RU94042465A (ru) Энантиомерный 1-фенил-2-(2-пиридинил) этиламин для лечения нейродегенеративных расстройств
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
RU94046144A (ru) Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция
GEP19991780B (en) Use of Pyrrolidine Derivatives for Treating Alcoholism
ES2098338T3 (es) Heteroarilmetilbencenos.
RU94040719A (ru) 2,3,4,5-тетрагидро-1h-3-бензазепины, фармацевтическая композиция, способ лечения и способ получения
RU94033096A (ru) Соединение, способ лечения и фармацевтическая композиция

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
BAP Processing applications according to articles 230 and 231 of law 9.279/96: publication of application for third parties submission of comments
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96